The EU AI Act: Implications for Startups, Innovation, and Investment | LSI Europe '24

This panel took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.

The recent EU AI Act has significant penalties and implications for existing and prospecting tech companies and investors. This panel covers these new policies from the perspective of Medtech innovators.

This panel featured:

Sophie Ehrlich — EIT Health

Anjany Sekuboyina — Bonescreen

Andreu Climent — Corify Care

Andreas Schriefl — eMurmur

Jordina Arcal — MJN Neuroserveis

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social:

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw